Christopher M. Schroeder is a leading American entrepreneur and investor in interactive technologies and social communications. He co-founded HealthCentral.com, one of the largest content and social platforms in health and wellness. Backed by Polaris Ventures, Sequoia Capital, The Carlyle Group, Allen & Company, and Interactive Corp., the company was sold in 2012. He remains a board adviser. 

Schroeder was previously CEO and publisher of washingtonpost.newsweek interactive, which hosted washingtonpost.com, newsweek.msnbc.com, and slate.com, among other leading news sites. He also ran LEGI-SLATE.com, a leading B2B provider of information on federal and state legislation and regulation, which he sold.

Schroeder is an investor in and adviser for a series of technology startups and venture capital funds in news and media, education, social networks, eCommerce, and marketing. He is also the author of the best-seller “Startup Rising: The Entrepreneurial Revolution Remaking the Middle East”.

Schroeder serves on the boards of the American University of Cairo School of Business; the American University School of International Service; the American Council on Germany; Planet Forward, George Washington University's media platform on global environment; wamda.com, the leading entrepreneurship platform in the Middle East; and Oasis500, a Jordan-based startup incubator. 

He is a co-founder and former chairman of the Online Publishers Association, a leading research and information organization comprised of the CEOs of top online publishers. He also served as a board member of Interactive Advertising Bureau. He was named a LinkedIn top 50 Influencer.

Schroeder speaks extensively about the internet, consumer behavior, and entrepreneurship, and has written for The Washington Post, The Wall Street Journal, Newsweek, Fortune, Fast Company, AllThingsD, Pando Daily, TechCrunch, and the Harvard Business Review, among others. He has appeared regularly on television and on National Public Radio. He graduated magna cum laude from Harvard College and, with honors, from Harvard Business School.

Susannah Gray was the executive vice president and chief financial officer of Royalty Pharma, the largest aggregator of pharmaceutical royalty interests worldwide, from January 2005 through 2018. In 2019, she took on the additional responsibility of heading strategy for the company. Prior to joining Royalty Pharma, she had a 14-year career in banking, working in various capacities within high-yield and structured finance departments at Chase Securities, Merrill Lynch, and CIBC World Markets. 

Gray currently serves on the board of directors of a number nonprofit and corporate organizations. She is a member board of Wesleyan University, the Susan G. Komen Foundation, Street Squash, and the German Marshall Fund. In addition, she serves on the board of directors of 4D Molecular Therapeutics and Maravai Life Sciences. She earned a bachelor’s degree with honors from Wesleyan University in 1982 and an MBA from Columbia University in 1990.